ABCELLERA BIOLOGICS (8QQ) — Defensive Interval Ratio
ABCELLERA BIOLOGICS (8QQ) has a Defensive Interval Ratio of 3010 days as of June 2026. Defensive assets of €438.64 Million (cash €-, short-term investments €420.04 Million, receivables €18.60 Million) cover 3010 days of daily cash needs of €145.72K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ABCELLERA BIOLOGICS Defensive Interval Ratio (2021–2025)
This chart shows how ABCELLERA BIOLOGICS's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 3010 days, meaning defensive assets of €438.64 Million can fund 3010 days of operations without new revenue. For the complete balance sheet picture, see 8QQ current and non-current assets.
Annual Defensive Interval Ratio for ABCELLERA BIOLOGICS (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for ABCELLERA BIOLOGICS from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See 8QQ working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2631 days | €463.61 Million | €176.18K/day | €- | €405.31 Million | ▲ +235 days |
| 2024 | 2396 days | €502.90 Million | €209.90K/day | €- | €469.29 Million | ▲ +378 days |
| 2023 | 2018 days | €657.86 Million | €326.06K/day | €- | €627.26 Million | ▲ +356 days |
| 2022 | 1661 days | €538.54 Million | €324.16K/day | €- | €499.95 Million | ▲ +429 days |
| 2021 | 1232 days | €407.41 Million | €330.62K/day | €- | €246.84 Million | — |